Form 4: C3.ai Director Richard C. Levin Acquires Stock Options
SEC Form 4 Filing
Director Richard C. Levin acquired stock options in C3.ai, Inc. on October 2, 2024.
Summary
- Richard C. Levin, a director of C3.ai, Inc., acquired stock options on October 2, 2024.
- The options grant the right to buy 23,642 shares of Class A Common Stock at an exercise price of $22.89.
- The options vest quarterly, starting October 2, 2024, provided Levin remains a director and attends board meetings.
- If Levin misses a board meeting, the vesting of 5% of the shares will be suspended and may vest only after the fifth anniversary of the vesting commencement date if attendance requirements are met in subsequent periods.
- The options expire on October 1, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard transaction (stock option grant) and suggests confidence in the company's leadership and future, hence a moderately positive sentiment.
Positives
- The acquisition of stock options by a director signals confidence in the company's future performance.
Risks
- The vesting schedule is contingent on the director's continued service and attendance at board meetings, which introduces a potential risk if these conditions are not met.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule implies an expectation of continued service by the director.
Industry Context
Stock option grants are a common form of executive compensation in the technology industry, aligning the interests of directors and shareholders.
Comparison to Industry Standards
- Stock option grants are a typical component of compensation packages for directors in publicly traded technology companies.
- The vesting schedule tied to board meeting attendance is a mechanism to ensure active participation and engagement from the director.
- Comparable companies such as Palantir, Snowflake, and Databricks also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of shareholders, potentially driving long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of the transaction (acquisition of stock options) and Vesting Commencement Date. |
| 10/01/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.